###begin article-title 0
###xml 23 28 <span type="species:ncbi:9606">human</span>
Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression 
###end article-title 0
###begin p 1
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 579 584 <span type="species:ncbi:9606">human</span>
###xml 1419 1424 <span type="species:ncbi:9606">human</span>
###xml 1664 1669 <span type="species:ncbi:9606">human</span>
Progesterone is a critical regulator of normal female reproductive function, with diverse tissue-specific effects in the human. The effects of progesterone are mediated by its nuclear receptor (PR) that is expressed as two isoforms, PRA and PRB, which are virtually identical except that PRA lacks 164 amino acids that are present at the N-terminus of PRB. Considerable in vitro evidence suggests that the two PRs are functionally distinct and in animals, tissue-specific distribution patterns of PRA and PRB may account for some of the diversity of progesterone effects. In the human, PRA and PRB are equivalently expressed in most target cells, suggesting that alternative mechanisms control the diversity of progesterone actions. PR mediates the effects of progesterone by association with a range of coregulatory proteins and binding to specific target sequences in progesterone-regulated gene promoters. Ligand activation of PR results in redistribution into discrete subnuclear foci that are detectable by immunofluorescence, probably representing aggregates of multiple transcriptionally active PR-coregulator complexes. PR foci are aberrant in cancers, suggesting that the coregulator composition and number of complexes is altered. A large family of coregulators is now described and the range of proteins known to bind PR exceeds the complement required for transcriptional activation, suggesting that in the human, tissue-specific coregulator expression may modulate progesterone response. In this review, we examine the role of nuclear localization of PR, coregulator association and tissue-specific expression in modulating progesterone action in the human.
###end p 1
###begin title 2
###xml 52 57 <span type="species:ncbi:9606">human</span>
: Reported patterns of PR coregulator expression in human tissues.
###end title 2
###begin p 3
###xml 108 113 <span type="species:ncbi:9606">human</span>
The findings of studies reporting expression of known PR coregulators at the transcript or protein level in human tissues are summarised.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 335 358 335 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r37" ref-type="bibr">Graham and Clarke, 1997</xref>
###xml 360 383 360 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r38" ref-type="bibr">Graham and Clarke, 2002</xref>
###xml 385 400 385 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r78" ref-type="bibr">Li et al., 2004</xref>
###xml 402 419 402 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r94" ref-type="bibr">Mote et al., 2007</xref>
###xml 562 587 562 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lonard and O'Malley, 2007</xref>
###xml 621 650 621 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r3" ref-type="bibr">Arnett-Mansfield et al., 2004</xref>
###xml 652 681 652 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 927 938 927 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r14" ref-type="bibr">Beral, 2003</xref>
###xml 940 953 940 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r50" ref-type="bibr">Holtorf, 2009</xref>
###xml 955 968 955 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r51" ref-type="bibr">Horwitz, 2008</xref>
###xml 970 986 970 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r75" ref-type="bibr">Lee et al., 2005</xref>
###xml 988 1005 988 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r104" ref-type="bibr">Pike et al., 2007</xref>
###xml 1007 1027 1007 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r110" ref-type="bibr">Rossouw et al., 2002</xref>
###xml 1029 1041 1029 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r113" ref-type="bibr">Santen, 2003</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Progesterone is an essential regulator of normal human female reproductive function in the uterus, ovary, mammary gland and brain, and also plays an important role in non-reproductive tissues such as the cardiovascular system, bone and the central nervous system, highlighting the widespread role of this hormone in normal physiology [Graham and Clarke, 1997; Graham and Clarke, 2002; Li et al., 2004; Mote et al., 2007]. The effects of progesterone are mediated through the nuclear progesterone receptor (PR), which interacts with transcriptional coregulators [Lonard and O'Malley, 2007], moves into nuclear aggregates [Arnett-Mansfield et al., 2004; Arnett-Mansfield et al., 2007] and regulates gene expression. Although progesterone plays a pivotal role in normal physiology, exposure to its analogues in exogenous hormone formulations is associated with deleterious effects, most notably an increase in breast cancer risk [Beral, 2003; Holtorf, 2009; Horwitz, 2008; Lee et al., 2005; Pike et al., 2007; Rossouw et al., 2002; Santen, 2003]. Given the diverse roles of progesterone in normal tissues and in cancer, developing a detailed understanding of the mechanisms that direct its cell and tissue specificity is a high priority. This review will explore the role of nuclear localization of PR, its association with coregulators, and coregulator complement of target tissues as critical contributors to the selectivity and specificity of progesterone effects in normal and malignant target tissues.
###end p 5
###begin title 6
The progesterone receptor
###end title 6
###begin p 7
###xml 175 195 175 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r26" ref-type="bibr">Escriva et al., 2004</xref>
###xml 197 208 197 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r28" ref-type="bibr">Evans, 1988</xref>
###xml 210 222 210 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r85" ref-type="bibr">McEwan, 2009</xref>
###xml 705 718 705 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r25" ref-type="bibr">Edwards, 2000</xref>
###xml 720 737 720 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r54" ref-type="bibr">Huse et al., 1998</xref>
###xml 739 751 739 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r85" ref-type="bibr">McEwan, 2009</xref>
###xml 753 773 753 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r86" ref-type="bibr">McKenna et al., 1999</xref>
###xml 775 801 775 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r88" ref-type="bibr">McKenna and O'Malley, 2002</xref>
###xml 803 825 803 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r114" ref-type="bibr">Sartorius et al., 1994</xref>
###xml 827 846 827 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r130" ref-type="bibr">Vegeto et al., 1993</xref>
###xml 943 961 943 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r121" ref-type="bibr">Smith et al., 1990</xref>
###xml 1069 1087 1069 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r105" ref-type="bibr">Pratt et al., 2004</xref>
###xml 1403 1421 1403 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r13" ref-type="bibr">Beato et al., 1987</xref>
###xml 1423 1439 1423 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r43" ref-type="bibr">Gronemeyer, 1991</xref>
###xml 1441 1451 1441 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r122" ref-type="bibr">Tata, 2002</xref>
Progesterone effects are mediated by binding to the nuclear progesterone receptor (PR). PR is a member of a large family of ligand-activated nuclear transcription regulators [Escriva et al., 2004; Evans, 1988; McEwan, 2009], which are characterised by organisation into specific functional domains and are conserved, to differing degrees, between species and family members. PR is made up of a central DNA binding domain (DBD) and a carboxyl-terminal ligand-binding domain (LBD). In addition, the receptor contains multiple activation (AF) and inhibitory (IF) function elements, which enhance and repress transcriptional activation of PR by association of these regions with transcriptional coregulators [Edwards, 2000; Huse et al., 1998; McEwan, 2009; McKenna et al., 1999; McKenna and O'Malley, 2002; Sartorius et al., 1994; Vegeto et al., 1993]. Newly-transcribed cytoplasmic PR is assembled in an inactive multi-protein chaperone complex [Smith et al., 1990], which is essential for maintenance of the inactive receptor in a state that is competent to bind ligand [Pratt et al., 2004]. Progestin binding to PR causes a conformational change leading to dissociation of chaperones, dimerization, binding to progestin response elements in the promoters of target genes and recruitment of specific coactivators and general transcription factors, resulting in modulation of transcription of those genes [Beato et al., 1987; Gronemeyer, 1991; Tata, 2002].
###end p 7
###begin p 8
###xml 246 264 246 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r69" ref-type="bibr">Lange et al., 1998</xref>
###xml 266 288 266 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r76" ref-type="bibr">Leonhardt et al., 2003</xref>
###xml 290 314 290 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r100" ref-type="bibr">Nilsen and Brinton, 2002</xref>
###xml 316 340 316 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r101" ref-type="bibr">Nilsen and Brinton, 2003</xref>
###xml 524 543 524 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r22" ref-type="bibr">Daniel et al., 2007</xref>
###xml 545 566 545 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r59" ref-type="bibr">Jacobsen et al., 2005</xref>
###xml 747 759 747 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r67" ref-type="bibr">Lange, 2008a</xref>
###xml 761 773 761 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r68" ref-type="bibr">Lange, 2008b</xref>
In addition to the ligand-activated transcriptional effects discussed above, which reflect the nuclear activity of this receptor, PR also regulates transcription via non-genomic pathways such as activation of second messenger signaling cascades [Lange et al., 1998; Leonhardt et al., 2003; Nilsen and Brinton, 2002; Nilsen and Brinton, 2003]. Ligand-independent activation of PR can occur in a cell-type and promoter-specific manner and provides evidence for regulation of PR via cytoplasmic and membrane generated signals [Daniel et al., 2007; Jacobsen et al., 2005]. The molecular mechanisms of PR action through non-genomic mechanisms, including receptor cross-talk with growth factor signaling pathways, have been reviewed in detail recently [Lange, 2008a; Lange, 2008b], and this review will not explore these issues further.
###end p 8
###begin title 9
Progesterone action is mediated by two PR isoforms
###end title 9
###begin p 10
###xml 188 211 188 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r44" ref-type="bibr">Gronemeyer et al., 1991</xref>
###xml 213 233 213 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r62" ref-type="bibr">Kastner et al., 1990</xref>
###xml 446 466 446 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r62" ref-type="bibr">Kastner et al., 1990</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
In the human, the effects of progesterone are mediated by two distinct forms of the PR transcribed from a single gene by alternate initiation of transcription from two distinct promoters [Gronemeyer et al., 1991; Kastner et al., 1990], giving rise to transcripts encoding two protein isoforms, PRA and PRB. PRA and PRB are identical in sequence, except that PRA lacks 164 amino acids at the N-terminus, making it the shorter of the two proteins [Kastner et al., 1990].
###end p 10
###begin p 11
###xml 313 339 313 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r6" ref-type="bibr">Aupperlee and Haslam, 2007</xref>
###xml 341 361 341 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r16" ref-type="bibr">Brayman et al., 2006</xref>
###xml 363 384 363 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r58" ref-type="bibr">Jacobsen et al., 2002</xref>
###xml 386 405 386 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r109" ref-type="bibr">Richer et al., 2002</xref>
###xml 407 424 407 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r127" ref-type="bibr">Tung et al., 1993</xref>
###xml 584 612 584 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r97" ref-type="bibr">Mulac-Jericevic et al., 2003</xref>
###xml 689 717 689 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r98" ref-type="bibr">Mulac-Jericevic et al., 2000</xref>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
Considerable evidence from transient cotransfection studies into a variety of cell lines suggest that PRA and PRB are functionally unique transcriptional regulators, capable of differentially regulating gene transcription within the same promoter context, and capable of recognising entirely different promoters [Aupperlee and Haslam, 2007; Brayman et al., 2006; Jacobsen et al., 2002; Richer et al., 2002; Tung et al., 1993]. In the mouse, ablation of PRA or PRB has revealed the unique roles for PRA and PRB, demonstrating that PRB is required for normal mammary gland development [Mulac-Jericevic et al., 2003], while PRA is essential for uterine development and reproductive function [Mulac-Jericevic et al., 2000].
###end p 11
###begin p 12
###xml 254 276 254 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r114" ref-type="bibr">Sartorius et al., 1994</xref>
###xml 433 457 433 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r1" ref-type="bibr">Abdel-Hafiz et al., 2002</xref>
###xml 459 476 459 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r126" ref-type="bibr">Tung et al., 2006</xref>
###xml 576 593 576 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r8" ref-type="bibr">Bain et al., 2000</xref>
###xml 595 612 595 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r9" ref-type="bibr">Bain et al., 2001</xref>
###xml 721 739 721 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r123" ref-type="bibr">Tetel et al., 1999</xref>
###xml 1015 1038 1015 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r33" ref-type="bibr">Giangrande et al., 2000</xref>
###xml 1040 1061 1040 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r49" ref-type="bibr">Heneghan et al., 2007</xref>
###xml 1063 1092 1063 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r90" ref-type="bibr">Molenda-Figueira et al., 2008</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 1180 1185 <span type="species:ncbi:9606">human</span>
Although the precise mechanisms underlying the differential activities of the two human PR isoforms is not fully understood, structure-function studies suggest that the AF3 domain located within the PRB upstream sequence region, which is absent in PRA, [Sartorius et al., 1994] contributes to PRB transcriptional activity by suppressing the activity of an inhibitory domain (ID) contained within the sequences common to PRA and PRB [Abdel-Hafiz et al., 2002; Tung et al., 2006]. Moreover, evidence suggests that the two receptors adopt distinct conformations within the cell [Bain et al., 2000; Bain et al., 2001] allowing PRA to interact with a set of coregulators that are different from those which interact with PRB [Tetel et al., 1999]. This is supported by studies demonstrating that PRA has a higher affinity for the corepressor SMRT than PRB in the presence of PR antagonists, and PRA does not interact directly or with as high an affinity as PRB with the coactivators SRC-1 and SRC-2 upon agonist binding [Giangrande et al., 2000; Heneghan et al., 2007; Molenda-Figueira et al., 2008], potentially contributing to differences in the transcriptional activities of the two human PR isoforms and further enhancing the complexity of this regulatory system.
###end p 12
###begin p 13
###xml 414 430 414 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r133" ref-type="bibr">Wei et al., 1990</xref>
###xml 432 448 432 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r134" ref-type="bibr">Wei et al., 1996</xref>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 565 584 565 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r20" ref-type="bibr">Condon et al., 2006</xref>
###xml 586 602 586 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r134" ref-type="bibr">Wei et al., 1996</xref>
###xml 604 620 604 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r135" ref-type="bibr">Wei et al., 1997</xref>
###xml 674 681 674 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 744 773 744 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r112" ref-type="bibr">Samalecos and Gellersen, 2008</xref>
In addition to the translation start sites driving expression of PRA and PRB, a third start site within the PR gene has been identified at amino acid position 595 that could give rise to a truncated PR isoform, PRC. If expressed, PRC would lack the PR N-terminus and one zinc finger of the DNA binding domain, rendering it transcriptionally inactive but able to bind hormone, dimerize and localize in the nucleus [Wei et al., 1990; Wei et al., 1996]. Although in vitro reports have suggested that PRC may either enhance or antagonize the activities of PRA and PRB [Condon et al., 2006; Wei et al., 1996; Wei et al., 1997], recent evidence suggests that PRC is not expressed in vivo and has no real physiological role in progesterone signaling [Samalecos and Gellersen, 2008].
###end p 13
###begin p 14
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Relative expression of the PR isoforms contributes to selectivity of PR action.</bold>
Relative expression of the PR isoforms contributes to selectivity of PR action. Much of our current understanding of the distinct functions of PRA and PRB derives from models where only a single PR isoform is expressed and in which the PR homodimer is the dominant molecular species. However, in a cell that co-expresses both PR isoforms, there is the potential for 3 molecular species (PRB homodimers, PRA homodimers and PRA-PRB heterodimers) to exist concurrently and to contribute to the complexity of PR action.
###end p 14
###begin p 15
###xml 103 120 103 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r32" ref-type="bibr">Gava et al., 2004</xref>
###xml 122 139 122 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r91" ref-type="bibr">Mote et al., 2006</xref>
###xml 321 349 321 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r97" ref-type="bibr">Mulac-Jericevic et al., 2003</xref>
###xml 351 379 351 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r98" ref-type="bibr">Mulac-Jericevic et al., 2000</xref>
###xml 545 562 545 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r92" ref-type="bibr">Mote et al., 1999</xref>
###xml 564 581 564 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 583 600 583 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r94" ref-type="bibr">Mote et al., 2007</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
In mice, where PRA and PRB are frequently expressed in different cells within the reproductive system [Gava et al., 2004; Mote et al., 2006], the homodimer is clearly a critical contributor to progesterone action, consistent with the divergent and tissue-specific roles identified for these proteins in knockout studies [Mulac-Jericevic et al., 2003; Mulac-Jericevic et al., 2000]. In human physiology, however, the majority of PR positive cells express PRA and PRB at equivalent levels, and cells that express only one PR isoform are uncommon [Mote et al., 1999; Mote et al., 2002; Mote et al., 2007]. This suggests that in the human, progesterone exerts its effects in cells that co-express both PR isoforms, and that the PRA-PRB heterodimer is the predominant molecular species.
###end p 15
###begin p 16
###xml 155 163 155 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 427 446 427 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r109" ref-type="bibr">Richer et al., 2002</xref>
###xml 683 702 683 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r40" ref-type="bibr">Graham et al., 2005</xref>
###xml 704 723 704 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r109" ref-type="bibr">Richer et al., 2002</xref>
It appears that the PR dimer species that predominates within a target cell influences the transcriptional program regulated by the receptor. For example, in vitro studies in cell lines expressing only one PR isoform (PRA or PRB) have demonstrated that the gene sets regulated by PRA and PRB homodimers are largely non-overlapping and that the number of genes uniquely regulated by PRB far exceeds the number regulated by PRA [Richer et al., 2002]. Interestingly, in cell lines co-expressing both PRA and PRB, leading to the prevalence of the heterodimer, a unique and smaller number of genes are progesterone-regulated compared to that seen in cells expressing only one PR isoform [Graham et al., 2005; Richer et al., 2002]. Overall, these findings demonstrate that the PR homodimers and the heterodimer have the capacity to regulate different suites of genes and that the ratio of PR isoform expression plays an important role in influencing the transcriptional program regulated by PR in target tissues.
###end p 16
###begin p 17
###xml 201 226 201 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r19" ref-type="bibr">Chalbos and Galtier, 1994</xref>
###xml 228 258 228 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r34" ref-type="bibr">Giangrande and McDonnell, 1999</xref>
###xml 260 287 260 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r84" ref-type="bibr">McDonnell and Goldman, 1994</xref>
###xml 289 307 289 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r89" ref-type="bibr">Meyer et al., 1992</xref>
###xml 309 326 309 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r127" ref-type="bibr">Tung et al., 1993</xref>
###xml 328 347 328 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r130" ref-type="bibr">Vegeto et al., 1993</xref>
###xml 349 365 349 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r136" ref-type="bibr">Wen et al., 1994</xref>
###xml 552 579 552 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r84" ref-type="bibr">McDonnell and Goldman, 1994</xref>
###xml 581 598 581 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r127" ref-type="bibr">Tung et al., 1993</xref>
###xml 600 619 600 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r130" ref-type="bibr">Vegeto et al., 1993</xref>
###xml 621 637 621 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r136" ref-type="bibr">Wen et al., 1994</xref>
The PR isoform ratio also influences the capacity of PRA to regulate the activity of PRB. In transfection studies, PRA has been shown to be a dominant inhibitor of the transcriptional activity of PRB [Chalbos and Galtier, 1994; Giangrande and McDonnell, 1999; McDonnell and Goldman, 1994; Meyer et al., 1992; Tung et al., 1993; Vegeto et al., 1993; Wen et al., 1994]. Furthermore, PRA has been shown to similarly regulate the activity of a number of nuclear receptors, including the glucocorticoid, mineralocorticoid, androgen, and estrogen receptors [McDonnell and Goldman, 1994; Tung et al., 1993; Vegeto et al., 1993; Wen et al., 1994]. However, it appears that PRA can only exert this dominant negative effect when it is in very significant excess, as the transient transfection experiments that demonstrated the dominant negative inhibitory activity of PRA were likely to involve higher levels of PRA expression than are ever observed endogenously.
###end p 17
###begin p 18
###xml 392 411 392 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r40" ref-type="bibr">Graham et al., 2005</xref>
###xml 577 596 577 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r40" ref-type="bibr">Graham et al., 2005</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 980 985 <span type="species:ncbi:9606">human</span>
This possibility was explored through the construction of cell lines, normally containing equivalent levels of PRA and PRB in recapitulation of their relative levels observed in human tissues, but in which PRA expression can be induced to be in excess over PRB. In this model system, induction of PRA expression to five-fold excess over PRB had little impact on PR-regulated gene expression [Graham et al., 2005]. In particular, the progestin-regulated gene sets in cells expressing equivalent levels of PRA and PRB, and in cells over-expressing PRA, were largely overlapping [Graham et al., 2005]. This demonstrates that there is no dominant negative effect of PRA, when PRA is in physiological excess of PRB in cells endogenously co-expressing both PR isoforms. Most progesterone target tissues express both PRA and PRB at relative levels that are not vastly different, suggesting that dominant negative inhibition of PRB by PRA is not likely to be a prominent effect in normal human physiology.
###end p 18
###begin title 19
PR expression in target tissues
###end title 19
###begin p 20
###xml 172 183 172 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r15" ref-type="bibr">Bland, 2000</xref>
###xml 185 208 185 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r37" ref-type="bibr">Graham and Clarke, 1997</xref>
###xml 210 233 210 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r38" ref-type="bibr">Graham and Clarke, 2002</xref>
###xml 235 251 235 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r48" ref-type="bibr">Han et al., 2009</xref>
###xml 253 264 253 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r103" ref-type="bibr">Ozawa, 2005</xref>
###xml 266 287 266 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r125" ref-type="bibr">Tincello et al., 2009</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
PR proteins are expressed in a variety of human tissues, including the uterus, mammary gland, brain, pancreas, bone, ovary, testes, and tissues of the lower urinary tract [Bland, 2000; Graham and Clarke, 1997; Graham and Clarke, 2002; Han et al., 2009; Ozawa, 2005; Tincello et al., 2009]. The ubiquitous expression of PR highlights the widespread physiological effects that progesterone can exert in a variety of organs throughout the body.
###end p 20
###begin title 21
###xml 21 26 <span type="species:ncbi:9606">human</span>
PR expression in non-human species
###end title 21
###begin p 22
###xml 90 117 90 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r116" ref-type="bibr">Schrader and O'Malley, 1972</xref>
###xml 119 140 119 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r117" ref-type="bibr">Schrader et al., 1972</xref>
###xml 597 612 597 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chrysemys picta</italic>
###xml 615 638 615 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r36" ref-type="bibr">Giannoukos et al., 1995</xref>
###xml 640 663 640 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r108" ref-type="bibr">Reese and Callard, 1989</xref>
###xml 685 705 685 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r24" ref-type="bibr">Dufrene et al., 1989</xref>
###xml 753 770 753 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r66" ref-type="bibr">Lamb et al., 1986</xref>
###xml 846 868 846 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r115" ref-type="bibr">Schneider et al., 1991</xref>
###xml 870 891 870 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r119" ref-type="bibr">Shyamala et al., 1990</xref>
###xml 1003 1029 1003 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r56" ref-type="bibr">Ilenchuk and Walters, 1987</xref>
###xml 1031 1053 1031 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r115" ref-type="bibr">Schneider et al., 1991</xref>
###xml 1321 1344 1321 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r36" ref-type="bibr">Giannoukos et al., 1995</xref>
###xml 1437 1454 1437 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r63" ref-type="bibr">Kato et al., 1993</xref>
###xml 1746 1769 1746 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r36" ref-type="bibr">Giannoukos et al., 1995</xref>
###xml 56 61 <span type="species:ncbi:9031">chick</span>
###xml 597 612 <span type="species:ncbi:8479">Chrysemys picta</span>
###xml 719 725 <span type="species:ncbi:9986">rabbit</span>
###xml 901 906 <span type="species:ncbi:10090">mouse</span>
###xml 969 975 <span type="species:ncbi:10090">murine</span>
###xml 1358 1361 <span type="species:ncbi:10116">rat</span>
PRA and PRB proteins were initially demonstrated in the chick oviduct in the early 1970s [Schrader and O'Malley, 1972; Schrader et al., 1972] and many studies have since determined the relative levels of PRA and PRB isoforms in a variety of species including birds, reptiles, rodents and mammals. The majority of these early studies examined PR isoform expression using cell-free methods in organs associated with reproduction, and a dominant expression of one PR isoform was frequently observed. PRB was the dominant isoform in the oviduct of the reproductively active freshwater painted turtle (Chrysemys picta) [Giannoukos et al., 1995; Reese and Callard, 1989] and also the quail [Dufrene et al., 1989], whilst the rabbit uterus expressed only PRB [Lamb et al., 1986]. Conversely, rodent reproductive tissues expressed a predominance of PRA [Schneider et al., 1991; Shyamala et al., 1990]. In the mouse uterus and mammary gland the PRA:PRB ratio was 3:1, whilst in murine vaginal tissue it was 2:1 [Ilenchuk and Walters, 1987; Schneider et al., 1991]. Moreover, the relative expression levels of PRA and PRB varied in different organs within the same species, as the liver of the painted freshwater turtle expressed predominantly PRA, in contrast to the PRB-predominant expression in the oviduct of the same species [Giannoukos et al., 1995], whilst the rat brain, unlike the rodent reproductive organs, expressed predominantly PRB [Kato et al., 1993]. These data suggested the ratio of PRA and PRB to be both species- and tissue-specific. Seasonal changes in the relative expression of PRA and PRB in the turtle oviduct also occur, implying influence by circulating ovarian steroid hormones that fluctuate throughout the reproductive cycle [Giannoukos et al., 1995].
###end p 22
###begin p 23
###xml 478 495 478 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r91" ref-type="bibr">Mote et al., 2006</xref>
###xml 640 657 640 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r91" ref-type="bibr">Mote et al., 2006</xref>
###xml 742 759 742 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r32" ref-type="bibr">Gava et al., 2004</xref>
###xml 915 937 915 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r7" ref-type="bibr">Aupperlee et al., 2005</xref>
###xml 939 961 939 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r61" ref-type="bibr">Kariagina et al., 2007</xref>
###xml 1161 1183 1161 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r7" ref-type="bibr">Aupperlee et al., 2005</xref>
###xml 1286 1308 1286 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r61" ref-type="bibr">Kariagina et al., 2007</xref>
###xml 1487 1509 1487 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r61" ref-type="bibr">Kariagina et al., 2007</xref>
###xml 1856 1863 1856 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 971 976 <span type="species:ncbi:10090">mouse</span>
###xml 1248 1251 <span type="species:ncbi:10116">rat</span>
###xml 1684 1689 <span type="species:ncbi:10090">mouse</span>
The advent of antibodies with specificity for PRA or PRB demonstrated that the predominance of one PR isoform previously demonstrated in whole tissues by cell-free methods was contributed in part by cell-type specificity of PR isoform expression. For instance, the PRA predominance of mouse uterus identified in cell-free studies is contributed by high expression of PRA in the myometrium and stroma, whereas PRA is absent from luminal epithelial cells, which contain only PRB [Mote et al., 2006]. Both PR isoforms are present in the uterine stroma and myometrial cells, with levels that fluctuate with cyclical systemic hormonal exposure [Mote et al., 2006]. Similarly in the mouse ovary, there are estrous cycle-related changes in PRA:PRB [Gava et al., 2004]. There is also a temporal and/or spatial separation of PRA and PRB expression in rodent mammary epithelial cells during normal mammary gland development [Aupperlee et al., 2005; Kariagina et al., 2007]. In the mouse, PRA was the predominant isoform expressed in the pubertal and mature virgin mammary gland, whilst PRB predominance was observed during pregnancy when PRA and PRB rarely co-localized [Aupperlee et al., 2005]. Distinct PRA and PRB expression has also been reported in the rat mammary gland during development [Kariagina et al., 2007]. PRA was only expressed in luminal epithelial cells, whilst PRB was present in both luminal and myoepithelial cells, indicating a role for PRB in myoepithelial cell regulation [Kariagina et al., 2007]. The cell-specificity of PR isoform expression in animal tissues further supports the demonstration in PR isoform null animals of distinct activities of the isoforms in the mouse, and reflects the likelihood that progesterone action is mediated differentially in PRB-positive cells compared to PRA-positive cells within rodent PR-target tissues in vivo.
###end p 23
###begin title 24
###xml 21 26 <span type="species:ncbi:9606">human</span>
PR expression in the human
###end title 24
###begin p 25
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 234 251 234 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r92" ref-type="bibr">Mote et al., 1999</xref>
###xml 253 270 253 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 599 621 599 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r7" ref-type="bibr">Aupperlee et al., 2005</xref>
###xml 623 640 623 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r91" ref-type="bibr">Mote et al., 2006</xref>
###xml 1107 1124 1107 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r92" ref-type="bibr">Mote et al., 1999</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 707 712 <span type="species:ncbi:9606">human</span>
In contrast to the predominant expression of one PR isoform frequently observed in animal tissues, in normal human tissues in vivo, including the breast and uterus, all PR+ epithelial cells co-expressed PRA and PRB at similar levels [Mote et al., 1999; Mote et al., 2002]. This suggests that co-location and thus cooperative activity of PRA and PRB mediates PR action in the human. This is in contrast to the mouse, as outlined above, where the non-overlapping expression of PRA and PRB and the lack of co-location of the two PR isoforms, strongly suggest the PR homodimer to be the active species [Aupperlee et al., 2005; Mote et al., 2006]. Although PRA and PRB proteins are normally expressed equally in human tissues, there is some evidence for differential hormonal regulation of the two PR isoforms in the glandular epithelial cells of the endometrium. During the secretory phase of the menstrual cycle, when high circulating levels of progesterone are associated with decreased PR expression, PRA was preferentially decreased, resulting in a distinct predominance of PRB in these cells at this time [Mote et al., 1999].
###end p 25
###begin p 26
###xml 376 393 376 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 592 611 592 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r41" ref-type="bibr">Graham et al., 1995</xref>
###xml 613 630 613 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 835 864 835 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r4" ref-type="bibr">Arnett-Mansfield et al., 2001</xref>
###xml 999 1006 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1036 1053 1036 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 1168 1185 1168 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Mote et al., 2002</xref>
###xml 1318 1347 1318 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r4" ref-type="bibr">Arnett-Mansfield et al., 2001</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
In contrast to the balanced expression of PRA and PRB in normal human tissues, progression of breast and endometrial tissues from normal to malignancy is frequently accompanied by progressive changes in PR isoform expression. In normal breast and in proliferative disease without atypia of the breast, PRA and PRB are co-expressed within the same cells in comparable amounts [Mote et al., 2002], and there is little variation in the cell-to-cell relative expression of PRA and PRB. In atypical breast lesions, however, there is a significant increase in predominant expression of PRA or PRB [Graham et al., 1995; Mote et al., 2002]. Similarly, in hyperplastic areas of endometrial tissue there is increased predominance of one PR isoform, suggesting that lack of coordinated PRA:PRB expression is an early event in endometrial cancer [Arnett-Mansfield et al., 2001]. In breast cancer, PR isoform predominance, especially PRA predominance, is evident in a significant proportion of ductal carcinomas in situ (DCIS) and invasive cancers [Mote et al., 2002], and moreover, there is marked heterogeneity of PRA:PRB expression between neighbouring cells in breast cancers [Mote et al., 2002]. In endometrial cancers one PR isoform is frequently lost, and PR isoform loss is often associated with higher histological grade [Arnett-Mansfield et al., 2001].
###end p 26
###begin p 27
###xml 45 51 <span type="species:ncbi:9606">humans</span>
In summary, studies of PR expression in both humans and animals indicate that PRA and PRB proteins are expressed in a species-, tissue- and cell type-specific manner, highlighting the need for caution when extrapolating results between species. The data suggest that PRA and PRB are able to work both alone or together to modulate the complex and divergent pathways of progesterone action in normal and malignant physiology, and that the alterations in isoform expression frequently observed in malignancy, will affect PR dimer predominance and thereby modulate transcriptional response.
###end p 27
###begin title 28
Nuclear positioning of PR
###end title 28
###begin p 29
###xml 395 424 395 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r3" ref-type="bibr">Arnett-Mansfield et al., 2004</xref>
###xml 426 455 426 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 512 541 512 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r3" ref-type="bibr">Arnett-Mansfield et al., 2004</xref>
###xml 595 624 595 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 760 779 760 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r39" ref-type="bibr">Graham et al., 2009</xref>
###xml 935 954 935 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r39" ref-type="bibr">Graham et al., 2009</xref>
###xml 1102 1131 1102 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 1202 1231 1202 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 260 265 <span type="species:ncbi:9606">human</span>
Both liganded and unliganded PR are located in the cell nucleus, and localize to specific intra-nuclear locations: when liganded, the activated PR moves into nuclear aggregates, or 'foci', whereas unliganded PR is distributed evenly throughout the nucleus. In human tissues, endogenous PR is located in foci only in the secretory phase of the menstrual cycle, when progesterone levels are high [Arnett-Mansfield et al., 2004; Arnett-Mansfield et al., 2007]. Ligand binding is required for PR movement into foci [Arnett-Mansfield et al., 2004], and PR isoforms dimerise when they move into foci [Arnett-Mansfield et al., 2007]. PR foci are tethered to the nuclear matrix, and both DNA binding and nuclear matrix tethering are required for PR to move into foci [Graham et al., 2009]. Within these tethered structures PR is highly mobile, consistent with its rapid occupancy at specific chromatin locations associated with transcription [Graham et al., 2009]. Ligand-bound PR in foci co-locates with nascent RNA, activated RNAPolII, and also with the chromatin remodeling histone acetyl transferase p300 [Arnett-Mansfield et al., 2007] and transcriptional inhibitors inhibit the movement of PR into foci [Arnett-Mansfield et al., 2007], demonstrating the link between PR foci and transcriptional activity. Exposure to Roscovitine, which inhibits recruitment of the p160 coactivator SRC-1, also prevents ligand-dependent foci formation. These data collectively demonstrate that foci contain multiple activated PR-coactivator complexes associated with the basic transcriptional machinery.
###end p 29
###begin p 30
###xml 97 115 97 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r141" ref-type="bibr">Zaidi et al., 2004</xref>
###xml 117 134 117 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r142" ref-type="bibr">Zink et al., 2004</xref>
###xml 474 491 466 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r53" ref-type="bibr">Htun et al., 1999</xref>
###xml 518 536 510 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r128" ref-type="bibr">Tyagi et al., 2000</xref>
###xml 569 594 561 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r129" ref-type="bibr">van Steensel et al., 1995</xref>
###xml 633 656 625 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r29" ref-type="bibr">Fejes-Toth et al., 1998</xref>
###xml 706 729 698 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r29" ref-type="bibr">Fejes-Toth et al., 1998</xref>
###xml 731 748 723 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r52" ref-type="bibr">Htun et al., 1996</xref>
###xml 750 767 742 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r53" ref-type="bibr">Htun et al., 1999</xref>
###xml 769 787 761 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r128" ref-type="bibr">Tyagi et al., 2000</xref>
###xml 881 901 873 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r11" ref-type="bibr">Baumann et al., 2001</xref>
###xml 903 919 895 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r45" ref-type="bibr">Guo et al., 2000</xref>
###xml 1192 1197 <span type="species:ncbi:9606">human</span>
Nuclear aggregation of transcription factors, including nuclear receptors, is commonly observed [Zaidi et al., 2004; Zink et al., 2004], due to the structural constraints imposed by nuclear compartmentalization, and to the efficiency gains of co-location of functionally-related molecules. A number of components of nuclear receptor pathways have been shown to aggregate in the nucleus, and transfection of tagged receptors has shown that estrogen receptor alpha (ERalpha) [Htun et al., 1999], androgen receptor (AR) [Tyagi et al., 2000], glucocorticoid receptor (GR) [van Steensel et al., 1995] and mineralocorticoid receptor (MR) [Fejes-Toth et al., 1998] form nuclear aggregates when exposed to ligand [Fejes-Toth et al., 1998; Htun et al., 1996; Htun et al., 1999; Tyagi et al., 2000]. Furthermore, various nuclear receptor-associated proteins are located in discrete domains [Baumann et al., 2001; Guo et al., 2000] such as p53, steroid receptor coactivator (SRC), and glucocorticoid receptor interacting protein1 (GRIP1), which localize in the PML nuclear body. The frequent observation of nuclear aggregation of nuclear receptor components supports the view that PR foci identified in human tissues are transcriptional complexes required for progesterone action.
###end p 30
###begin p 31
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PR moves into different foci in cancer cells and normal cells.</bold>
###xml 313 342 305 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Arnett-Mansfield et al., 2007</xref>
###xml 461 490 453 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r3" ref-type="bibr">Arnett-Mansfield et al., 2004</xref>
###xml 560 589 552 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r3" ref-type="bibr">Arnett-Mansfield et al., 2004</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
PR moves into different foci in cancer cells and normal cells. While PR foci are detected in both normal human tissues and in cancers, they are different. PR foci in normal endometrium have a median length of 0.65 microm, but are significantly larger in endometrial cancers, with a median length over 1.0 microm [Arnett-Mansfield et al., 2007]. PR isoform composition in foci can be aberrant in cancers, with PRA seldom being found in foci, in contrast to PRB [Arnett-Mansfield et al., 2004], and foci in endometrial cancer are associated with clinical grade [Arnett-Mansfield et al., 2004]. The differences in PR foci in normal and cancer tissues suggest that PR foci in cancers may contain different and/or larger numbers of coregulator proteins, and may be functionally different. The link between PR foci in cancers and clinical features suggest that these observations have physiological and clinical relevance.
###end p 31
###begin title 32
###xml 65 70 <span type="species:ncbi:9606">human</span>
The role of PR coregulators in regulating progesterone action in human tissues
###end title 32
###begin p 33
###xml 885 904 885 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r80" ref-type="bibr">Lonard et al., 2007</xref>
###xml 906 931 906 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lonard and O'Malley, 2007</xref>
###xml 933 950 933 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r138" ref-type="bibr">Wolf et al., 2008</xref>
It is fascinating to realize that what can be seen at the microscopic level as PR foci, in fact represents active and highly mobile PR molecules engaged in transcriptional regulation of target genes and recruiting key coregulators to achieve this regulation. Binding of ligand to PR leads to receptor dimerization, conformational change, association with specific response element sequences in proximal and distal regions of target genes and regulation of transcription. This transcriptional regulation is a complex multistep process, which involves the sequential recruitment of a number of primary and secondary coactivators possessing a range of enzymatic activities. The complex combinatorial process of chromatin remodeling, coregulator recruitment and initiation of transcription by nuclear receptors is now well characterized and has been described in detail in recent reviews [Lonard et al., 2007; Lonard and O'Malley, 2007; Wolf et al., 2008], so only a brief summary is given here.
###end p 33
###begin p 34
###xml 153 169 153 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r46" ref-type="bibr">Han et al., 2006</xref>
###xml 171 187 171 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r47" ref-type="bibr">Han et al., 2005</xref>
###xml 189 209 189 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r87" ref-type="bibr">McKenna et al., 1998</xref>
###xml 211 229 211 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r102" ref-type="bibr">Onate et al., 1995</xref>
###xml 273 293 273 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r87" ref-type="bibr">McKenna et al., 1998</xref>
###xml 357 376 357 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r131" ref-type="bibr">Vicent et al., 2004</xref>
###xml 414 432 414 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r99" ref-type="bibr">Nawaz et al., 1999</xref>
###xml 455 480 455 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lonard and O'Malley, 2007</xref>
###xml 535 552 535 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r73" ref-type="bibr">Lanz et al., 1999</xref>
###xml 764 789 764 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lonard and O'Malley, 2007</xref>
The ligand-dependent change in PR conformation promotes recruitment of p160 coactivators (SRC-1/NCoA-1, SRC-2/GRIP1/TIF2, SRC-3/AIB1/ACTR/TRAM1/ p/CIP) [Han et al., 2006; Han et al., 2005; McKenna et al., 1998; Onate et al., 1995], histone acetylases (including p300/CBP) [McKenna et al., 1998], DNA helicases (including components of the SWI/SNF complex) [Vicent et al., 2004], ubiquitin ligases (such as E6-AP) [Nawaz et al., 1999], methylases (CARM1) [Lonard and O'Malley, 2007] and the steroid receptor-specific RNA activator SRA [Lanz et al., 1999]. This brings about histone modification and remodeling of the local chromatin to allow recruitment and activation of the RNA polymerase II holocomplex leading to increased RNA transcription of the target gene [Lonard and O'Malley, 2007].
###end p 34
###begin p 35
###xml 346 369 346 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r33" ref-type="bibr">Giangrande et al., 2000</xref>
###xml 371 387 371 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r47" ref-type="bibr">Han et al., 2005</xref>
###xml 389 408 389 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r80" ref-type="bibr">Lonard et al., 2007</xref>
###xml 493 501 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 663 679 663 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r46" ref-type="bibr">Han et al., 2006</xref>
###xml 681 710 681 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r90" ref-type="bibr">Molenda-Figueira et al., 2008</xref>
###xml 712 729 712 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r126" ref-type="bibr">Tung et al., 2006</xref>
More than 300 coregulators have now been described and more PR-binding coactivators exist than are required to form a functional PR activation complex. It has been hypothesized that the specific combination of coactivators that associate with PR in a given cell is dependent on their relative abundance, which varies in a tissue-specific manner [Giangrande et al., 2000; Han et al., 2005; Lonard et al., 2007]. Moreover, although no study has yet identified unique coregulators of PRA or PRB, in vitro evidence suggests that they have different affinities for a common set of coregulators, resulting in cell type-specific differences in transcriptional activity [Han et al., 2006; Molenda-Figueira et al., 2008; Tung et al., 2006].
###end p 35
###begin p 36
###xml 605 622 605 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r72" ref-type="bibr">Lanz et al., 2008</xref>
###xml 1116 1136 1116 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r57" ref-type="bibr">Jackson et al., 1997</xref>
###xml 1138 1156 1138 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r120" ref-type="bibr">Smith et al., 1997</xref>
###xml 1256 1277 1256 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r74" ref-type="bibr">Lavinsky et al., 1998</xref>
###xml 1279 1297 1279 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r120" ref-type="bibr">Smith et al., 1997</xref>
###xml 1459 1475 1459 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r30" ref-type="bibr">Gao et al., 2005</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 1685 1690 <span type="species:ncbi:9606">human</span>
###xml 1787 1792 <span type="species:ncbi:9606">human</span>
Given that PRA and PRB are equivalently expressed in most human target tissues, yet the effects of progesterone are highly tissue-specific, it is likely that variations in the levels of specific PR coregulators with distinct affinities for the two PR isoforms may provide a mechanism by which a functional predominance of PRA or PRB is achieved. It is clear that the level of coregulator expression is critical in determining the overall transcriptional activity of PR in target tissues, and there is now abundant evidence linking aberrant coregulator expression or activity to diseases including cancer [Lanz et al., 2008]. The identification of aberrant coregulator expression in cancers provides support for the view that recruitment of coregulators to PR is altered in cancers, as evidenced by aberrant PR foci observed in cancers compared to normal tissues. Although the corepressors N-CoR and SMRT play no role in normal PR physiology, they have been found to associate with PR and ER when bound to the mixed antagonists RU38486 and tamoxifen, respectively, to suppress the agonist effects of these compounds [Jackson et al., 1997; Smith et al., 1997]. Decreased expression of these corepressors may contribute to the tamoxifen resistance phenotype [Lavinsky et al., 1998; Smith et al., 1997]. It has also been suggested that differences in PR coregulator expression levels might account for variations in hormone responsiveness seen in the population [Gao et al., 2005]. In summary, variation in the level of both coactivators and corepressors of PR is likely to represent an important mechanism controlling responsiveness to progesterone in normal and malignant tissues in the human. Therefore, determining the tissue distribution and regulation of coregulator expression in the human is likely to be an important key to understanding the diversity of progesterone effects.
###end p 36
###begin title 37
The physiological role of PR coregulators in animal tissues
###end title 37
###begin p 38
###xml 498 513 498 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r139" ref-type="bibr">Xu et al., 2000</xref>
###xml 576 597 576 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r21" ref-type="bibr">Conneely et al., 2007</xref>
###xml 599 617 599 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r82" ref-type="bibr">Lydon et al., 1995</xref>
###xml 833 848 833 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r140" ref-type="bibr">Xu et al., 1998</xref>
###xml 1131 1154 1131 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r96" ref-type="bibr">Mukherjee et al., 2006b</xref>
###xml 1529 1545 1529 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r46" ref-type="bibr">Han et al., 2006</xref>
###xml 1685 1703 1685 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r60" ref-type="bibr">Jeong et al., 2007</xref>
###xml 2213 2232 2213 2232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r31" ref-type="bibr">Gao and Nawaz, 2002</xref>
###xml 2234 2249 2234 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r78" ref-type="bibr">Li et al., 2004</xref>
###xml 2251 2275 2251 2275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r111" ref-type="bibr">Rowan and O'Malley, 2000</xref>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">Mice</span>
###xml 1290 1295 <span type="species:ncbi:10090">mouse</span>
###xml 1618 1622 <span type="species:ncbi:10090">mice</span>
###xml 2251 2256 <span type="species:ncbi:36599">Rowan</span>
Much of the current understanding about the tissue-specific functions of PR coactivators has been derived from their ablation in animals. These studies have revealed that while some functional redundancy may exist between the p160 coactivator family members, there is a critical requirement for specific isoforms in progesterone target tissues. For example, disruption of the SRC-3 gene in mice causes severe growth and reproductive defects, including attenuation of mammary ductal side-branching [Xu et al., 2000], a developmental process shown to be driven by progesterone [Conneely et al., 2007; Lydon et al., 1995]. SRC-1 null mice also display specific aberrations, some of which are distinct from those observed in the SRC-3 knock-out model, such as attenuated decidual response in the uterus and elevated expression of SRC-2 [Xu et al., 1998]. Mice in which SRC-2 ablation is specifically directed to progesterone target cells reveal an essential role for this coactivator in mediating embryo implantation. These animals are infertile, lack a uterine decidual response and display markedly attenuated ductal side-branching [Mukherjee et al., 2006b]. In a study comparing the tissue-specific requirements for SRC-1 and SRC-3 for progesterone signaling, a PR activity indicator (PRAI) mouse model crossed into either an SRC-1 or SRC-3 null background confirmed that SRC-3 is the primary p160 coactivator for PR in the mammary gland, whereas the role of SRC-1 in modulating progesterone action is most evident in the uterus [Han et al., 2006]. There is clear evidence from combined studies of SRC-1 and SRC-2 null mice, displaying overlapping defects in uterine decidual response [Jeong et al., 2007], that these two coactivators function cooperatively to facilitate progesterone action in this tissue. In summary, these knock-out studies demonstrate that the three SRC isoforms play complementary tissue-specific roles in mediating progesterone action in the rodent, with SRC-1 and SRC-2 both playing essential roles in the uterus and SRC-3 being critical in the mammary gland. Animal model studies analysing the role of numerous other PR coregulators in reproductive function have previously been reviewed [Gao and Nawaz, 2002; Li et al., 2004; Rowan and O'Malley, 2000].
###end p 38
###begin title 39
###xml 75 80 <span type="species:ncbi:9606">human</span>
Expression of PR coregulators in normal progesterone target tissues in the human
###end title 39
###begin p 40
###xml 488 505 488 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r70" ref-type="bibr">Lanz et al., 2003</xref>
###xml 518 545 518 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r107" ref-type="bibr">Ramamoorthy and Nawaz, 2008</xref>
###xml 680 687 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="table-fn1">Table 1</xref>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
Despite the evidence that physiological response to progesterone in specific target tissues is affected by the combination and expression levels of PR coregulators, a comprehensive profile of coregulator expression is generally unavailable in these tissues in the human. However, some studies of individual coregulators have examined their expression in progesterone-responsive tissues, particularly the mammary gland and reproductive tissues, and in the case of two PR coregulators SRA [Lanz et al., 2003] and E6-AP [Ramamoorthy and Nawaz, 2008], wide-ranging surveys of tissue distribution in the human have been made. The collective findings of these studies are summarized in Table 1. In some cases, functional correlates have been sought, such as fluctuations in coregulator expression during the menstrual cycle or patterns of expression that overlap with PR. These will be discussed. We have attempted to highlight in each case, whether protein or transcript level has been measured, since levels of or fluctuations in transcript expression may not always correlate with what is observed at the protein level.
###end p 40
###begin p 41
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 137 161 137 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Kurebayashi et al., 2000</xref>
###xml 626 649 626 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r95" ref-type="bibr">Mukherjee et al., 2006a</xref>
###xml 651 674 651 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r96" ref-type="bibr">Mukherjee et al., 2006b</xref>
###xml 855 875 855 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r64" ref-type="bibr">Kershah et al., 2004</xref>
###xml 877 898 877 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r132" ref-type="bibr">Vienonen et al., 2004</xref>
###xml 955 975 955 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r64" ref-type="bibr">Kershah et al., 2004</xref>
###xml 1007 1027 1007 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r42" ref-type="bibr">Gregory et al., 2002</xref>
###xml 1029 1050 1029 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r118" ref-type="bibr">Shiozawa et al., 2003</xref>
###xml 1060 1080 1060 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r42" ref-type="bibr">Gregory et al., 2002</xref>
###xml 1082 1105 1082 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r96" ref-type="bibr">Mukherjee et al., 2006b</xref>
###xml 1118 1137 1118 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r10" ref-type="bibr">Balmer et al., 2006</xref>
###xml 1139 1159 1139 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r42" ref-type="bibr">Gregory et al., 2002</xref>
###xml 1264 1269 1264 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1483 1488 1483 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1573 1594 1573 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r118" ref-type="bibr">Shiozawa et al., 2003</xref>
###xml 1756 1775 1756 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r137" ref-type="bibr">Wieser et al., 2002</xref>
###xml 1802 1822 1802 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r42" ref-type="bibr">Gregory et al., 2002</xref>
###xml 1836 1855 1836 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r10" ref-type="bibr">Balmer et al., 2006</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
The expression of p160 steroid receptor coactivators has been examined in human breast, endometrium, brain and ovary. Kurebayashi et al [Kurebayashi et al., 2000] reported RNA transcript expression for all three SRC isoforms in a small cohort of normal breast tissues. SRC-1 was the most strongly expressed of all SRC coactivators, showing strong expression in all specimens, whereas SRC-2 and SRC-3 showed relatively weak expression. SRC-2 protein is detected in human mammary epithelium and results of PR staining of adjacent sections, coupled with evidence from dual detection in mouse tissues, suggest colocation with PR [Mukherjee et al., 2006a; Mukherjee et al., 2006b]. A number of investigators have also reported on SRC expression in the human endometrium. Transcript expression of all three SRC isoforms is detected in normal human endometrium [Kershah et al., 2004; Vienonen et al., 2004] and expression levels are similar for the three forms [Kershah et al., 2004]. Protein expression of SRC-1 [Gregory et al., 2002; Shiozawa et al., 2003], SRC-2 [Gregory et al., 2002; Mukherjee et al., 2006b] and SRC-3 [Balmer et al., 2006; Gregory et al., 2002] has also been reported in glandular epithelium and stroma in the endometrium, and the study of Gregory et al suggested that although expression levels were similar, SRC-3 staining was slightly lower than SRC-1 or SRC-2. Evidence for fluctuation in SRC expression during the normal menstrual cycle is conflicting. Shiozawa et al reported higher expression of SRC-1 protein in the proliferative phase endometrium [Shiozawa et al., 2003], whereas in another study SRC-1 RNA expression was found to be significantly higher at menstruation, compared to either proliferative or secretory endometrium [Wieser et al., 2002]. The studies of Gregory [Gregory et al., 2002] and Balmer [Balmer et al., 2006] reported no change in SRC-1 protein through the cycle, but observed an increase in SRC-3 in secretory phase endometrium. In summary, while there is suggestive evidence that coactivator expression in the endometrium may fluctuate during the menstrual cycle to modulate hormonal response, more studies are required to clarify the current observations.
###end p 41
###begin p 42
###xml 90 112 90 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r27" ref-type="bibr">Evangelou et al., 2003</xref>
###xml 146 177 146 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r55" ref-type="bibr">Hussein-Fikret and Fuller, 2005</xref>
###xml 385 405 385 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r18" ref-type="bibr">Carroll et al., 2000</xref>
###xml 780 798 780 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r124" ref-type="bibr">Tetel et al., 2007</xref>
###xml 501 506 <span type="species:ncbi:9606">human</span>
Transcripts for SRC1-3 have also been detected in surface epithelium of the normal ovary [Evangelou et al., 2003] and whole normal ovary samples [Hussein-Fikret and Fuller, 2005]. SRC expression is also detectable in the normal brain: immunoblot analysis of a small cohort of normal brain samples revealed consistent expression of SRC-1 and SRC-2, but SRC-3 was absent in all samples [Carroll et al., 2000]. Although limited information is available on the specificity of SRC expression in the normal human brain, studies in rodents have revealed that SRC-1 protein is present in regions of the hypothalamus that are functionally relevant to progesterone action in the brain, and cells that express PR generally also express SRC-1 and CBP, as detected by dual immunofluorescence [Tetel et al., 2007].
###end p 42
###begin p 43
###xml 273 297 273 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Kurebayashi et al., 2000</xref>
###xml 387 408 387 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r132" ref-type="bibr">Vienonen et al., 2004</xref>
###xml 563 584 563 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r118" ref-type="bibr">Shiozawa et al., 2003</xref>
Consistent with its role as a fundamental nuclear receptor coactivator, p300/CBP is detectable in all progesterone target tissues examined and there is not strong evidence for fluctuations in expression in normal tissues. CBP transcripts are detected in the normal breast [Kurebayashi et al., 2000] and both CBP and p300 transcripts have been detected in the endometrium and myometrium [Vienonen et al., 2004]. Shiozawa reported abundant expression of p300/CBP protein in normal endometrium, with slightly higher expression observed in proliferative endometrium [Shiozawa et al., 2003].
###end p 43
###begin p 44
###xml 227 244 227 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r70" ref-type="bibr">Lanz et al., 2003</xref>
###xml 500 516 500 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r30" ref-type="bibr">Gao et al., 2005</xref>
###xml 605 622 605 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r83" ref-type="bibr">Mani et al., 2006</xref>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hect</italic>
###xml 1004 1012 1004 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1033 1051 1033 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r99" ref-type="bibr">Nawaz et al., 1999</xref>
###xml 1443 1470 1443 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r107" ref-type="bibr">Ramamoorthy and Nawaz, 2008</xref>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 605 609 <span type="species:ncbi:156483">Mani</span>
###xml 1237 1242 <span type="species:ncbi:9606">human</span>
SRA, a PR coactivator which acts as an RNA, exhibits relatively high expression levels in the human pituitary gland, adrenal gland and liver, and relatively low levels of expression in the breast, ovaries, uterus and prostate [Lanz et al., 2003]. The coregulator E6-AP functions as a coactivator to several nuclear receptors including PR, ER and AR, via its role in the ubiquitin-proteasome pathway, where it is required for the degradation and proper turnover of numerous nuclear hormone receptors [Gao et al., 2005]. E6-AP also directs turnover of other PR-associated coactivators, such as AIB-1/SRC-3 [Mani et al., 2006], suggesting that E6-AP may play an important role in clearing the transcriptional coregulatory complex from a promoter region to allow for the subsequent interaction of activated receptor with a newly-assembled coactivator complex. The finding that the hect domain in E6-AP, which is involved in recruitment of ubiquitin conjugating enzymes, UbcH7 and UbcH8, is not essential for in vitro coactivation of PR [Nawaz et al., 1999], suggests that E6-AP also functions as a coactivator via mechanisms that are independent of its ubiquitin ligase function. Relative expression of E6-AP RNA transcripts in a variety of human tissues was found to be greatest in the lymph node, pineal gland and bladder, moderate in the placenta, uterus, brain, bone and liver, and lowest in the mammary gland, ovary, adrenal gland and blood [Ramamoorthy and Nawaz, 2008].
###end p 44
###begin p 45
###xml 84 108 84 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Kurebayashi et al., 2000</xref>
###xml 139 160 139 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r132" ref-type="bibr">Vienonen et al., 2004</xref>
Transcripts for the PR corepressors N-CoR and SMRT are detectable in mammary gland [Kurebayashi et al., 2000], endometrium and myometrium [Vienonen et al., 2004]. N-CoR was the predominant transcript detected in all three tissue types. As these observations were made in small cohorts of normal tissues collected from clinical specimens, where normal breast samples were obtained from breast cancer specimens by resection of adjacent normal tissue and normal endometrial tissue was derived from hysterectomy samples, it is debatable how normal these tissues may be considered to be, and additional studies in larger cohorts of validated normal tissues would be required to confirm these observations.
###end p 45
###begin title 46
Evidence for PR coregulators in disease progression and cancer
###end title 46
###begin p 47
###xml 168 185 168 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r72" ref-type="bibr">Lanz et al., 2008</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
There is now strong evidence that altered coregulator expression or activity occurs in a number of human pathologies, including cancers in progesterone target tissues [Lanz et al., 2008]. The general trend for PR coactivators is to be overexpressed and amplified in cancers, suggesting that increased availability of these proteins may enhance PR activity in tissues such as the breast, where it is known to play a role in cancer development. Overexpression in cancers of coregulators that are not normally abundant in a particular normal tissue, for example the breast or uterus, may allow PR to complex with coregulators in cancer tissues that it would not associate with in the corresponding normal tissue, and lead to changed target gene selection.
###end p 47
###begin p 48
###xml 240 259 240 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r2" ref-type="bibr">Anzick et al., 1997</xref>
###xml 322 339 322 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r79" ref-type="bibr">List et al., 2001</xref>
###xml 547 566 547 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r2" ref-type="bibr">Anzick et al., 1997</xref>
###xml 716 735 716 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r2" ref-type="bibr">Anzick et al., 1997</xref>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 881 902 881 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r12" ref-type="bibr">Bautista et al., 1998</xref>
###xml 1103 1123 1103 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r64" ref-type="bibr">Kershah et al., 2004</xref>
###xml 1138 1157 1138 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r10" ref-type="bibr">Balmer et al., 2006</xref>
###xml 1257 1276 1257 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r10" ref-type="bibr">Balmer et al., 2006</xref>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
Among the PR coregulators known to be associated with malignancy, SRC-3 is the best characterized. Initially identified as Amplified In Breast cancer-1 (AIB-1), SRC-3 is often highly expressed and amplified in primary human breast cancers [Anzick et al., 1997] and amplification is correlated with elevated protein level [List et al., 2001]. A screen of 105 unselected specimens of primary breast cancer revealed SRC-3 amplification in approximately 10% of primary tumors and this amplification was correlated with elevated transcript expression [Anzick et al., 1997]. In addition, elevated SRC-3 expression relative to normal mammary epithelium was detected in 58% of tumors in which no amplification was detected [Anzick et al., 1997], indicating that overexpression of SRC-3 by mechanisms other than amplification also occurs frequently in human breast cancers. Bautista et al [Bautista et al., 1998] demonstrated increased SRC-3 copy number in 4.8% of breast tumors and 7.4% of ovarian tumors and amplification in breast cancers was positively correlated with ER and PR. Increased SRC-3 transcript [Kershah et al., 2004] and protein [Balmer et al., 2006] expression was also reported in endometrial cancers and was correlated with ER and PR positivity [Balmer et al., 2006].
###end p 48
###begin p 49
###xml 101 121 101 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r18" ref-type="bibr">Carroll et al., 2000</xref>
###xml 123 143 123 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r64" ref-type="bibr">Kershah et al., 2004</xref>
###xml 145 162 145 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r72" ref-type="bibr">Lanz et al., 2008</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 260 280 260 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r42" ref-type="bibr">Gregory et al., 2002</xref>
###xml 614 634 614 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r18" ref-type="bibr">Carroll et al., 2000</xref>
###xml 636 653 636 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r72" ref-type="bibr">Lanz et al., 2008</xref>
###xml 363 368 <span type="species:ncbi:9606">women</span>
Overexpression of SRC-2 and SRC-3 has also been reported in endometrial, prostate and brain cancers [Carroll et al., 2000; Kershah et al., 2004; Lanz et al., 2008], supporting their role in enhanced hormone responsiveness in these malignancies. Gregory et al [Gregory et al., 2002] showed an increased level of expression of SRC-2 and SRC-3 in the endometrium of women with polycystic ovarian syndrome, a condition known to be associated with a higher risk of endometrial cancer. Elevated expression of SRC-2 was reported in meningiomas, compared to normal brain, and expression was correlated with PR expression [Carroll et al., 2000; Lanz et al., 2008].
###end p 49
###begin p 50
###xml 263 281 263 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r106" ref-type="bibr">Proia et al., 2006</xref>
###xml 318 326 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 328 346 328 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r106" ref-type="bibr">Proia et al., 2006</xref>
###xml 437 457 437 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r17" ref-type="bibr">Bulavin et al., 2002</xref>
###xml 459 474 459 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r77" ref-type="bibr">Li et al., 2002</xref>
###xml 716 723 716 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 732 748 732 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r30" ref-type="bibr">Gao et al., 2005</xref>
###xml 1119 1135 1119 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r30" ref-type="bibr">Gao et al., 2005</xref>
Altered expression of coregulators that can impact on SRC function has also been reported. The magnesium-dependent protein phosphatase PPM1D has been reported to enhance the intrinsic activity of p160 coactivators and to promote interaction between PR and SRC-1 [Proia et al., 2006]. PPM1D, which enhanced PR activity in vitro [Proia et al., 2006], was amplified and overexpressed in breast cancer cell lines and primary breast cancers [Bulavin et al., 2002; Li et al., 2002]. As described above, the ubiquitin ligase function of E6-AP is required for proper turnover of coactivators, as well as nuclear receptors. E6-AP was lower in invasive breast cancer than in adjacent normal mammary tissue or ductal carcinoma in situ (DCIS) [Gao et al., 2005], suggesting that reduced ubiquitin ligase activity may contribute to the elevation in p160 coactivator levels often observed in breast cancers. The expression of E6-AP in DCIS was not different from normal tissue, suggesting that the downregulation of E6-AP protein is a relatively late event in the development of cancer and is associated with the invasive phenotype [Gao et al., 2005]. Consistent with its role in ER and PR turnover, E6-AP protein level was inversely correlated with expression of ERalpha, suggesting that loss of this coregulator may augment hormone signaling in breast cancers.
###end p 50
###begin p 51
###xml 334 351 334 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r73" ref-type="bibr">Lanz et al., 1999</xref>
###xml 752 769 752 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r70" ref-type="bibr">Lanz et al., 2003</xref>
###xml 479 494 <span type="species:ncbi:10090">transgenic mice</span>
In a survey of several cancer types, SRA was overexpressed in over 90% of ovarian primary tumor samples, 100% of uterine samples, and 90% of breast tumors, compared to increased expression in fewer than 35% of tumors of the pancreas and kidney, suggesting that the upregulation of SRA was specific for hormone-dependent malignancies [Lanz et al., 1999]. This is in contrast to the relatively lower expression of SRA in normal hormone-responsive tissues. Overexpression of SRA in transgenic mice resulted in precocious lobular-alveolar development of the mammary gland during pregnancy, thus supporting the assertion that overexpression of SRA in the breast may enhance progesterone action and in this way could contribute to breast cancer development [Lanz et al., 2003].
###end p 51
###begin p 52
###xml 95 119 95 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Kurebayashi et al., 2000</xref>
###xml 146 166 146 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r64" ref-type="bibr">Kershah et al., 2004</xref>
Overexpression of transcripts for the corepressors N-CoR and SMRT has been reported in breast [Kurebayashi et al., 2000] and endometrial cancers [Kershah et al., 2004]. Both of these studies are relatively preliminary and the impact of transcript overexpression on protein levels has not been determined. Moreover, since these corepressors only affect PR action in the context of mixed antagonists, their overexpression in progesterone target tissues is unlikely to play a role in progesterone-related breast cancer etiology.
###end p 52
###begin p 53
In summary, the studies discussed suggest that amplification and/or altered expression of PR coregulators is a relatively common event in hormone-dependent malignancies, which appears likely to have functional consequences for progesterone signaling in those tissues, particularly if elevated abundance of coregulators enhances steroid responsiveness in cancer tissues.
###end p 53
###begin title 54
Summary and conclusion
###end title 54
###begin p 55
When bound to progesterone, PR activates target gene transcription in a diverse range of target tissues such as the breast, uterus, brain, central nervous and cardiovascular systems. The effects of progesterone on these target tissues are diverse, and the evidence to date supports the view that coregulators play a critical role in regulating the magnitude and nature of the biological response to progesterone, and contribute to the expression of a diverse subset of progesterone-regulated genes and specificity of progesterone action in target tissues.
###end p 55
###begin p 56
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 243 262 243 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r80" ref-type="bibr">Lonard et al., 2007</xref>
###xml 264 289 264 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lonard and O'Malley, 2007</xref>
###xml 685 690 <span type="species:ncbi:9606">human</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
The pool of coregulators that are able to associate with PR, and the complex series of steps involved in receptor activation, coregulator association and ultimately transcriptional activation have now been defined by elegant in vitro studies [Lonard et al., 2007; Lonard and O'Malley, 2007]. However, it is clear that there is a surplus of potential PR interactors, and the nature of endogenous PR-coregulator complexes that actually form in true target tissues has not been explored. Delineation of the role of coregulators in the specificity of PR action in target tissues will require demonstrating a functional association between the progesterone receptor and its coregulators in human tissues and identification of the PR coregulators required for progesterone action in human physiology.
###end p 56
###begin p 57
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
Although the expression and role of PR coregulators has been extensively studied in vitro and in animal models, it has become evident that few studies have looked comprehensively at PR coregulator levels and function in human tissues, making it difficult to assess whether the differences in progesterone action can be attributed to specific coregulator interactions with PR. Nevertheless, disparity in PR coregulator expression in various human tissues, such as in the endometrium throughout the different phases of the menstrual cycle, suggest that PR coregulators do play an important role in regulating the tissue-specific response to progesterone.
###end p 57
###begin p 58
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
Demonstration of the co-location of PR and coregulators by in situ methods such as immunofluorescence in target tissues is an essential first step in demonstrating a functional association that potentially contributes to the specificity of PR action. Very few studies in human tissues have explored co-location of PR and coregulators, and of those that have, none have distinguished between expression of the two PR isoforms and the differential coregulator affinities of PRA and PRB. As co-location is a correlative measure of association, direct measurement of PR-coregulator association, ideally performed on primary human cells, may allow for the identification of coregulatory proteins existing in a complex with the PR, providing support for a functional association. Such studies would also contribute to the identification of PR coregulators that are required for progesterone action in the various cell types in which this receptor is active in normal physiology.
###end p 58
###begin p 59
It is essential to identify PR coregulators required for PR to move into nuclear foci, as these coregulators are likely to play a direct role in regulating the specific effects of progesterone in normal tissues and in cancers. The aberrant formation of PR foci in cancers suggests that PR forms complexes with different and/or larger numbers of coregulatory proteins in these tissues, potentially leading to functionally different PR foci in normal and malignant cells. An analysis of PR coregulators involved in PR foci formation is required to identify PR coregulators directly involved in modulating progesterone effects in normal tissues and cancers.
###end p 59
###begin p 60
###xml 620 639 620 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r23" ref-type="bibr">Dawson et al., 1996</xref>
A significant challenge in identifying coregulators required for progesterone action arises from the fact that nuclear receptors are highly related, sharing the same structural features and utilizing a common pool of coregulator partners to regulate transcription. All coregulators that have been demonstrated to interact with PR, also interact with numerous other nuclear receptors such as ER and AR, and interact with unrelated transcription factors. Furthermore, evidence suggests that coregulators can control cellular functions outside of the nucleus such as mRNA translation, mitochondrial function, and motility [Dawson et al., 1996].
###end p 60
###begin p 61
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
In summary, it has become clear that studies of coregulators, their interaction with the PR, and the downstream effects of such interactions in progesterone target tissues in the human, are still in their infancy. Further studies are required to uncover the role of PR coregulators in human tissues and the impact of variation in their level of expression on progesterone action in human cells and tissues.
###end p 61
###begin title 62
Abbreviations
###end title 62
###begin p 63
 actin-related protein
###end p 63
###begin p 64
 activation function
###end p 64
###begin p 65
 amplified in breast cancer-1
###end p 65
###begin p 66
 androgen receptor
###end p 66
###begin p 67
 coactivator-associated arginine methyltransferase 1
###end p 67
###begin p 68
 CREB binding protein
###end p 68
###begin p 69
 DNA-binding domain
###end p 69
###begin p 70
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
 ductal carcinoma in situ
###end p 70
###begin p 71
 E6-associated protein
###end p 71
###begin p 72
 estrogen receptor alpha
###end p 72
###begin p 73
 glucocorticoid receptor-interacting protein 1
###end p 73
###begin p 74
 inhibitory function
###end p 74
###begin p 75
 ligand-binding domain
###end p 75
###begin p 76
 nuclear receptor coactivator 1
###end p 76
###begin p 77
 nuclear receptor corepressor
###end p 77
###begin p 78
 p300/CBP interacting protein
###end p 78
###begin p 79
 promyelocytic leukemia
###end p 79
###begin p 80
 protein phosphatase 1D magnesium dependent
###end p 80
###begin p 81
 progesterone receptor
###end p 81
###begin p 82
 progesterone receptor A
###end p 82
###begin p 83
 progesterone receptor B
###end p 83
###begin p 84
 progesterone receptor C
###end p 84
###begin p 85
 silencing mediator for retinoid and thyroid hormone
###end p 85
###begin p 86
 steroid receptor RNA activator
###end p 86
###begin p 87
 steroid receptor coactivator-1
###end p 87
###begin p 88
 steroid receptor coactivator-2
###end p 88
###begin p 89
 steroid receptor coactivator-3
###end p 89
###begin p 90
 switch/sucrose nonfermentable
###end p 90
###begin p 91
 transcription intermediary factor 2
###end p 91
###begin p 92
 thyroid hormone receptor activator molecule 1
###end p 92
###begin p 93
 ubiquitin conjugating enzyme H7
###end p 93
###begin p 94
 ubiquitin conjugating enzyme H8
###end p 94
###begin article-title 95
###xml 27 32 <span type="species:ncbi:9606">human</span>
The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression
###end article-title 95
###begin article-title 96
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
###end article-title 96
###begin article-title 97
Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity
###end article-title 97
###begin article-title 98
Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium
###end article-title 98
###begin article-title 99
Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium
###end article-title 99
###begin article-title 100
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland
###end article-title 100
###begin article-title 101
###xml 94 100 <span type="species:ncbi:10090">murine</span>
Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development
###end article-title 101
###begin article-title 102
###xml 25 30 <span type="species:ncbi:9606">human</span>
The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors
###end article-title 102
###begin article-title 103
###xml 29 34 <span type="species:ncbi:9606">human</span>
The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain
###end article-title 103
###begin article-title 104
Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers
###end article-title 104
###begin article-title 105
The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome
###end article-title 105
###begin article-title 106
In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity
###end article-title 106
###begin article-title 107
Gene regulation by steroid hormones
###end article-title 107
###begin article-title 108
###xml 61 66 <span type="species:ncbi:9606">Women</span>
Breast cancer and hormone-replacement therapy in the Million Women Study
###end article-title 108
###begin article-title 109
Steroid hormone receptor expression and action in bone
###end article-title 109
###begin article-title 110
Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells
###end article-title 110
###begin article-title 111
###xml 26 31 <span type="species:ncbi:9606">human</span>
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
###end article-title 111
###begin article-title 112
Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas
###end article-title 112
###begin article-title 113
###xml 40 45 <span type="species:ncbi:9606">human</span>
Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription
###end article-title 113
###begin article-title 114
Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function
###end article-title 114
###begin article-title 115
Progesterone signaling in mammary gland development
###end article-title 115
###begin article-title 116
Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth
###end article-title 116
###begin article-title 117
MCF10AT: a model for the evolution of cancer from proliferative breast disease
###end article-title 117
###begin article-title 118
Biochemical characterization and subunit structure of quail oviduct progesterone receptor
###end article-title 118
###begin article-title 119
The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors
###end article-title 119
###begin article-title 120
The evolution of the nuclear receptor superfamily
###end article-title 120
###begin article-title 121
Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells
###end article-title 121
###begin article-title 122
The steroid and thyroid hormone receptor superfamily
###end article-title 122
###begin article-title 123
Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists
###end article-title 123
###begin article-title 124
Decreased expression of e6-associated protein in breast and prostate carcinomas
###end article-title 124
###begin article-title 125
Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer
###end article-title 125
###begin article-title 126
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle
###end article-title 126
###begin article-title 127
###xml 28 33 <span type="species:ncbi:9606">human</span>
The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene
###end article-title 127
###begin article-title 128
###xml 67 72 <span type="species:ncbi:9606">human</span>
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
###end article-title 128
###begin article-title 129
Turtle oviduct progesterone receptor: radioligand and immunocytochemical studies of changes during the seasonal cycle.
###end article-title 129
###begin article-title 130
Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells
###end article-title 130
###begin article-title 131
###xml 64 69 <span type="species:ncbi:9606">human</span>
Characterization of progesterone receptor A and B expression in human breast cancer
###end article-title 131
###begin article-title 132
Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells
###end article-title 132
###begin article-title 133
Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci
###end article-title 133
###begin article-title 134
Physiological action of progesterone in target tissues
###end article-title 134
###begin article-title 135
Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium
###end article-title 135
###begin article-title 136
Progestin receptors: isoforms and antihormone action
###end article-title 136
###begin article-title 137
Transcription activation by estrogen and progesterone receptors
###end article-title 137
###begin article-title 138
The function of PML in p53-dependent apoptosis
###end article-title 138
###begin article-title 139
###xml 86 89 <span type="species:ncbi:9606">men</span>
Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia
###end article-title 139
###begin article-title 140
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Dynamic cell type specificity of SRC-1 coactivator in modulating uterine progesterone receptor function in mice
###end article-title 140
###begin article-title 141
Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor
###end article-title 141
###begin article-title 142
Coactivator assembly at the promoter: efficient recruitment of SRC2 is coupled to cooperative DNA binding by the progesterone receptor
###end article-title 142
###begin article-title 143
The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
###end article-title 143
###begin article-title 144
The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk
###end article-title 144
###begin article-title 145
###xml 28 33 <span type="species:ncbi:9606">human</span>
Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor
###end article-title 145
###begin article-title 146
Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera
###end article-title 146
###begin article-title 147
###xml 50 55 <span type="species:ncbi:9606">human</span>
Definition of a negative modulation domain in the human progesterone receptor
###end article-title 147
###begin article-title 148
Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours
###end article-title 148
###begin article-title 149
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat uterine progesterone receptor analyzed by [3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar
###end article-title 149
###begin article-title 150
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
###end article-title 150
###begin article-title 151
###xml 4 9 <span type="species:ncbi:9606">human</span>
New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation
###end article-title 151
###begin article-title 152
###xml 36 41 <span type="species:ncbi:9606">human</span>
Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology
###end article-title 152
###begin article-title 153
###xml 58 64 <span type="species:ncbi:10090">murine</span>
The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and -dependent gene expression
###end article-title 153
###begin article-title 154
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Progesterone receptor isoforms and proliferation in the rat mammary gland during development
###end article-title 154
###begin article-title 155
###xml 103 108 <span type="species:ncbi:9606">human</span>
Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
###end article-title 155
###begin article-title 156
###xml 69 72 <span type="species:ncbi:10116">rat</span>
The ontogeny of gene expression of progestin receptors in the female rat brain
###end article-title 156
###begin article-title 157
###xml 69 74 <span type="species:ncbi:9606">human</span>
Expression of estrogen receptor coregulators in normal and malignant human endometrium
###end article-title 157
###begin article-title 158
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer
###end article-title 158
###begin article-title 159
###xml 53 59 <span type="species:ncbi:9986">rabbit</span>
Evidence for a single steroid-binding protein in the rabbit progesterone receptor
###end article-title 159
###begin article-title 160
Challenges to defining a role for progesterone in breast cancer
###end article-title 160
###begin article-title 161
Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways
###end article-title 161
###begin article-title 162
Integration of progesterone receptor action with rapid signaling events in breast cancer models
###end article-title 162
###begin article-title 163
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex
###end article-title 163
###begin article-title 164
Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo
###end article-title 164
###begin article-title 165
###xml 33 38 <span type="species:ncbi:9606">human</span>
Nuclear receptor coregulators in human diseases.
###end article-title 165
###begin article-title 166
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
###end article-title 166
###begin article-title 167
An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk
###end article-title 167
###begin article-title 168
Progesterone receptor transcription and non-transcription signaling mechanisms
###end article-title 168
###begin article-title 169
A contemporary understanding of progesterone receptor function
###end article-title 169
###begin article-title 170
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23
###end article-title 170
###begin article-title 171
Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue
###end article-title 171
###begin article-title 172
###xml 34 39 <span type="species:ncbi:9606">human</span>
Nuclear receptor coregulators and human disease
###end article-title 172
###begin article-title 173
Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation
###end article-title 173
###begin article-title 174
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
###end article-title 174
###begin article-title 175
E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells
###end article-title 175
###begin article-title 176
RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
###end article-title 176
###begin article-title 177
Nuclear receptors: one big family
###end article-title 177
###begin article-title 178
Combinatorial control of gene expression by nuclear receptors and coregulators
###end article-title 178
###begin article-title 179
Distinct steady-state nuclear receptor coregulator complexes exist in vivo
###end article-title 179
###begin article-title 180
Nuclear receptor coregulators: cellular and molecular biology
###end article-title 180
###begin article-title 181
###xml 75 80 <span type="species:ncbi:9606">human</span>
A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms
###end article-title 181
###begin article-title 182
Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes
###end article-title 182
###begin article-title 183
###xml 93 98 <span type="species:ncbi:9606">human</span>
Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle
###end article-title 183
###begin article-title 184
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis
###end article-title 184
###begin article-title 185
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Overlapping and distinct expression of progesterone receptors A and B in mouse uterus and mammary gland during the estrous cycle
###end article-title 185
###begin article-title 186
Progesterone receptor isoforms in normal and malignant breast
###end article-title 186
###begin article-title 187
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse
###end article-title 187
###begin article-title 188
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: insights from the mouse--implications for the human
###end article-title 188
###begin article-title 189
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
###end article-title 189
###begin article-title 190
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
###end article-title 190
###begin article-title 191
The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily
###end article-title 191
###begin article-title 192
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling
###end article-title 192
###begin article-title 193
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate
###end article-title 193
###begin article-title 194
Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
###end article-title 194
###begin article-title 195
Steroid Hormones, their receptors and neuroendocrine system
###end article-title 195
###begin article-title 196
Estrogens, progestins, and risk of breast cancer
###end article-title 196
###begin article-title 197
Role of molecular chaperones in steroid receptor action
###end article-title 197
###begin article-title 198
Dual roles for the phosphatase PPM1D in regulating progesterone receptor function
###end article-title 198
###begin article-title 199
E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors
###end article-title 199
###begin article-title 200
###xml 67 82 <span type="species:ncbi:8479">Chrysemys picta</span>
Two progesterone receptors in the oviduct of the freshwater turtle Chrysemys picta: possible homology to mammalian and avian progesterone receptor systems
###end article-title 200
###begin article-title 201
###xml 74 79 <span type="species:ncbi:9606">human</span>
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells
###end article-title 201
###begin article-title 202
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 106 111 <span type="species:ncbi:9606">Women</span>
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
###end article-title 202
###begin article-title 203
Progesterone receptor coactivators
###end article-title 203
###begin article-title 204
Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms
###end article-title 204
###begin article-title 205
Risk of breast cancer with progestins: critical assessment of current data
###end article-title 205
###begin article-title 206
###xml 42 47 <span type="species:ncbi:9606">human</span>
A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform
###end article-title 206
###begin article-title 207
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form
###end article-title 207
###begin article-title 208
###xml 35 40 <span type="species:ncbi:9031">chick</span>
Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits
###end article-title 208
###begin article-title 209
###xml 32 37 <span type="species:ncbi:9031">chick</span>
Progesterone-binding protein of chick oviduct. VI. Interaction of purified progesterone-receptor components with nuclear constituents
###end article-title 209
###begin article-title 210
###xml 97 102 <span type="species:ncbi:9606">human</span>
Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium
###end article-title 210
###begin article-title 211
###xml 28 34 <span type="species:ncbi:10090">murine</span>
Developmental regulation of murine mammary progesterone receptor gene expression
###end article-title 211
###begin article-title 212
Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
###end article-title 212
###begin article-title 213
Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins
###end article-title 213
###begin article-title 214
Signalling through nuclear receptors
###end article-title 214
###begin article-title 215
Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors
###end article-title 215
###begin article-title 216
Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo
###end article-title 216
###begin article-title 217
Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract
###end article-title 217
###begin article-title 218
###xml 20 25 <span type="species:ncbi:9606">human</span>
Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors
###end article-title 218
###begin article-title 219
Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B
###end article-title 219
###begin article-title 220
Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells
###end article-title 220
###begin article-title 221
Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus
###end article-title 221
###begin article-title 222
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function
###end article-title 222
###begin article-title 223
DNA instructed displacement of histones H2A and H2B at an inducible promoter
###end article-title 223
###begin article-title 224
###xml 49 54 <span type="species:ncbi:9606">human</span>
Expression of nuclear receptors and cofactors in human endometrium and myometrium
###end article-title 224
###begin article-title 225
###xml 20 25 <span type="species:ncbi:9606">human</span>
5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages
###end article-title 225
###begin article-title 226
An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity
###end article-title 226
###begin article-title 227
An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding
###end article-title 227
###begin article-title 228
###xml 28 33 <span type="species:ncbi:9606">human</span>
The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells
###end article-title 228
###begin article-title 229
###xml 73 78 <span type="species:ncbi:9606">human</span>
Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation
###end article-title 229
###begin article-title 230
Coactivators and nuclear receptor transactivation
###end article-title 230
###begin article-title 231
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
###end article-title 231
###begin article-title 232
The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development
###end article-title 232
###begin article-title 233
Intranuclear trafficking: organization and assembly of regulatory machinery for combinatorial biological control
###end article-title 233
###begin article-title 234
Nuclear structure in cancer cells
###end article-title 234

